← Back to Search

FSI-R Treatment for Family Research

N/A
Waitlist Available
Led By Theresa Betancourt, ScD
Research Sponsored by Boston College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t1 (baseline), t2 (approximately 24-months post-baseline), t3 (6-months follow-up from t2)
Awards & highlights

Study Summary

This study is evaluating whether a home-visiting program can help refugee children and families.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t1 (baseline), t2 (approximately 24-months post-baseline), t3 (6-months follow-up from t2)
This trial's timeline: 3 weeks for screening, Varies for treatment, and t1 (baseline), t2 (approximately 24-months post-baseline), t3 (6-months follow-up from t2) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in communication via the Revised Parent- Adolescent Communication Form
Change in conflict via the Family Conflict Scale
Change in family conflict via the Intergenerational Conflict Index
+1 more
Secondary outcome measures
Change in youth depression via the Center for Epidemiologic Studies-Depression scale
Change in youth externalizing behaviors via the African Youth Psychosocial Assessment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FSI-R TreatmentExperimental Treatment1 Intervention
Families randomized into the FSI-R Treatment arm will receive the 10-module Family Strengthening Intervention in addition to any outside services or programs they are participating in.
Group II: FSI-R ControlActive Control1 Intervention
Families randomized into the FSI-R Control arm will not receive the FSI-R treatment. Instead, they will continue with their usual care, referred to as Treatment as Usual (TAU).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FSI-R Treatment
2018
N/A
~360

Find a Location

Who is running the clinical trial?

Boston CollegeLead Sponsor
37 Previous Clinical Trials
46,965 Total Patients Enrolled
Theresa Betancourt, ScDPrincipal InvestigatorBoston College
1 Previous Clinical Trials
265 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~54 spots leftby Apr 2025